Ouachita Baptist University

Scholarly Commons @ Ouachita
Honors Theses

Carl Goodson Honors Program

1979

The Recombinant DNA Debate
Richard E. Brown
Ouachita Baptist University

Follow this and additional works at: https://scholarlycommons.obu.edu/honors_theses
Part of the Cells Commons

Recommended Citation
Brown, Richard E., "The Recombinant DNA Debate" (1979). Honors Theses. 610.
https://scholarlycommons.obu.edu/honors_theses/610

This Thesis is brought to you for free and open access by the Carl Goodson Honors Program at Scholarly
Commons @ Ouachita. It has been accepted for inclusion in Honors Theses by an authorized administrator of
Scholarly Commons @ Ouachita. For more information, please contact mortensona@obu.edu.

1-1 r·c;7 . J- 7 2 5 J

1? " ()

OUACHITA BAPTIST UNIVERSITY
HONORS INDEPENDENT STUDY

THE RECOMBINANT DNA DEBA'l'E

·.

Richard E. Brown, Jr.
April 10, 1979

The questions surrounding the recombinant DNA research
debate are not just questions of technique and safety.

They

involve the driving forces of scientific research, especially
those premises and presuppositions concerning the

exp~nsion

of knowledge versus our ability to use that knowledge wisely.
Basically, we ask if policy--scientific, industrial, or
political--should be an integral part of our future steps in
recombinant DNA research and development.
It is obvious from past mistakes involving pollution,
waste of fossil fuels, and

overmechanization that we must

try to avoid the crucial tendency that technology has of
overrunning common sense and moral guidelines.

This is

especially true in light of the fact that we are looking at
an area of research in which results are probably the most
unpredictable of any area of biochemistry.

There comes a

point at which the scientist, seeing himself as providing
good for mankind, becomes hostile at the thought of the
regulator burdening down progress with red tape. The regulator,
on the other hand, views the scientist as being too ambitious
and uncontrolled, and sees himself as a protector of the
"real world" from the eccentricities of the research scientist.
In the recombinant DNA question, this conflict becomes
strikingly real.

The techniques and ideas are no longer

hypothetical or theory; they are available for widespread
use.
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A method of reducing risks while 1uaintaining the potential
benefits of recombinant DNA research must be found.

On this

point, there seems to be widespread agreement among scientists
and lay-people.

The· real debate begins when the regulations for

accomplishing this goal are proposed.

Not only are the regulations

themselves debated, but the validity of them is also a focal
point of debate.

Here, the challenge to validity comes from the

rapidly changing knowledge concerning recombinant DNA techniques.
Possibly, the answer is not in a set of £ixed rules, but in rules
that can be easily accommodated to current knowledge without endangering the public or the environment.
Therefore, the following is a review of facts concerning
recombinant DNA research, starting with the basic premises of
molecular genetics and then reviewing National Institutes of
Health guidelines, testimony before the United States House of
Representatives Subcommittee on Science and Technology, and
transcripts of the National Academy of Sciences' Forum on Recombinant DNA research.

Within this review, the risks, benefits,

and existing regulations will be discussed, concluding with a
general summary and commentary.

It is hoped that this paper will

serve as an informative summary of the author's three semester
study of the recombinant DNA research policy . debate.
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To understand the nature of deoxyribonucleic acids,
hereafter referred to as DNA, one must f·irst gain an appreciation
for the cell.s and some viruses in which

DNA

directs chemical

re.actions in the cycles which we recognize as life.

In the

case of viruses, the distinction betw·e en life and mere
chemical reactions is still not clear, but the basic mechanisms
of chemistry that are involved are the same as for the cells.
The separation of organic and inorqanic chemistry, as in
livinq and nc:m-livinq, has no real bioloqical basis.
However, even throuqh the first quarter of the twentieth
century, there was a stronq tendency towards a theory of
"vitalism", that certain rules outside of the laws of chemistry
differentiated between living and non-living entities. 1

As

techniques became more sophisticated, the existence of certain
macromolecules, especially proteins, was demonstrated.

It

was not until the elucidation of the bas.ic structure of proteins
as being alpha helical that immense strides were tnade towards
understanding basic chemistry which determines the direction
. .

of l1fe.

2

The direction of biochemical research before the eluci-

dation of the

m<::~lecular

structure' of proteins was toward studies

on metabolism of the cell.

3

However, as metabolic pathways

within the cell were worked out, it was found that a specific
enzyme must mediate each step of individual pathways.
came especially

obv~ous.

This be-

in the elucidation of the Embden-Meyerhof

pathway, which is the stepwise degradation of glucos.e to pyruvic
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acid.

It was noted that enzymes caused reactions between

molecules to occur at an increased rate, yet at a lower
energy level than the reaction would normally require, i.e.
at a lowered activation energy.

4

Yet the manner of the

initial formation of enzymes was still unknown.
It is here that the role of DNA became of prime interest.
Together with its associated proteins, DNA was discovered in
1890 by the German chemist, Miescher, in the nuclei obtained from
pus.

By the use of specific staining procedures, DNA was localized

in the chromosomes in the nuclei of cells by Feulgen in 1924,
and 20 years later, DNA was shown to be the crucial molecule of
heredity by Avery, McCarty, and McLeod. 5

Chargaff, by use of

paper chromatography, was able to anal.·ze the nucleotide composition of DNA molecules from a number of organisms.

He showed that

the four nucleotides are not found in equal amounts and that their
ratios to each other vary from species to species.

This opened

up the possibility of genetic specificity according to precise
nucleotide arrangement.

It later became evident that the amount

of adenine was always equal to the amount of thymine, and the
amount of guanine was always equal to the amount of cytosine.
The real impact of these results was not really evident until
the three dimensional structure of DNA was established.6
The development of x-ray diffraction analysis proved to be a
tremendous asset in working out the structure of DNA.

Using tech-

niques developed in the X-ray analysis of proteins, high quality
diffraction patterns were obtained by Wilkins and Franklin,

5

working in London at King's College in 1952.

Then in 1953,

following the theories of X-ray diffraction established by
scientists working on protein structure, Watson and Crick
were able to deduce the structure of DNA as being a complementary
double helix.

This was a momentous breakthrough, as scientists

now had a real molecular object about which they could think
obiectivelv in terms of established chemical mechanisms such
as hydrogen bonding.

Immediately, the mechanism for replication

could be theorized as one strand serving as a template for
the building of another complementary strand.

It was at

this point that molecular genetics had its beqinnings. 7
The area of recombinant DNA research is deeply involved
in the fundamentals of molecular biology, thus a rigorous
treatment of the subject would seem most appropriate.
However, it seems prudent to give a more concise and relevant
background, thus we will look at what DNA is and then point
out some of its activity in a living system.
DNA is the macromolecule that is the principal component
of the chromosome, the structure within the cell that is the
storage place for the "information'' necessary to sustain the
cell in the living state.

The cell that we speak of may be

a single-celled bacteria or one of a group of cells which
form a higher organism.

In either case, each cell carries

the information it needs to sustain the organism.

Not all

of the information is used at once; instead, the chromosome
also carries mechanisms for the timinq of gene expression,

6
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dependinq on staqe of development or surroundinq conditions.
The DNA molecule itself varies in lenqth from orqanism
to orqanism and usually consists of two complementary polymeric
chains twisted about each other in the form of a reqular
double helix.

Each chain is a polynucleotide, each nucleotide

beinq made up of a nitroqen base, a deoxyribose suqar and a
phosphate qroup.

There are four nitrogen bases:

guanine, adenine, and thymine.

cytosine,

The two chains are joined

together by weak bonds between complementary bases, that is,
cytosine is always paired with guanine and adenine is always
paired with thymine. 9 The number of different DNA molecules
caused by arrangements of nucleotides is given by the expression
4n, where n is the number of nucleotides in a given molecule. 10
Even in an extremely small virus, ~uch as tl74, with only a
single stranded DNA, there are 5,375 nucleotides, or 4 53 95
possible combinations. In a mammalian cell, there are approximately
7
11
1 x 10 nucleotides.
Replication of DNA occurs by the unwinding of the
strands and attachment of free deoxynucleoside-triphosphates
to their now unpaired complementary nucleotides.

It should

be noted that some lower bacteria that do not have well
defined nuclei, called prokaryotic cells, have single stranded
DNA which replicates by a somewhat different mechanism, but
complementary base pairing is still the essential step. 12
In the case of the making of a protein, the weak bonds
that make r e p l icati on possible also make the first step of
protein synthesis, transcription, possible.

Again, complementary

7

bases attach to the DNA, but this time they are attached to
ribose sugars instead of deoxyribose s·,;gars.

Another difference

is that the nucleotide thymine is replaced by uracil.

Thus,

when the polynucleotide-ribose sugar chain is complete·, it
detaches and is known as RNA.

It has the same information

that DNA has, with the exception that each RNA nucleotide is the
complement of the corresponding nucleotide on the original DNA
strand.

An important point here is that any mistake made in

the copying of DNA will be continued through successive
replications, but since RNA is not a self-replicating molecule,
any mistake made in its transcription will not be propagated
and will usually result in a nonfunctional protein being
produced, if one is produced at a11.

13

The RNA strand contains successive bases which are "read"
in a process called transcription by other RNA molecules
with amino acids attached.

The RNA units which result from

transcription from DNA are known as messenger RNAs(m-RNA),
while the RNA units that ·"read" the m-RNAs and link the
proper proteins together are known as trans.fer RNAs, or t-RNAs.
The t-RNA contains approximately 80 nucleotides in a chain
that folds by means of weak bonds into a cloverleaf shape.
Each loop of the cloverleaf (Fig.l) has a particular function;
one loop binds to the ribosomal surface, another recognizes
activating enzymes, and there is an area containing the
anticodon, and an open end which holds the amino acid moiety
which will become part of the protein to be made.
The start of protein synthesis

(Fig.2) is the moving of

8
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The above figure is a schematic diagram of a t- RNA
molecule, attaching by means of its anticodon to the
complementary bases of the codon on m- RNA.
Both m- RNA
and t- RNA are single stranded polynucleotides.
Loops
are formed by hydrogen bonding of complementary nucleotides
within the t-RNA molecule.
1.

Binding to the ribosomal surface may involve this
loop.

2.

Anticodon loop.

3.

Possibly involved in binding to activating enzymes.

"Leu" represents the amino acid leucine, which will be
positioned in the growing amino acid chain.

9
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Psife
Growing polypeptide chain, attached
by a t-RNA group to the protein
binding site.

J

2.

The next amino acid enters the amino
acyl site attached to another t-RNA.
A specific enzyme mediates the transfer of the first two amino acids to the
third amino acid.

3.

Ejection of t-RNA from the

4.

Growing polypeptide chain moves from
the · "A" site to the 11 P" site .
S i mu 1taneously, the m-RNA moves to place
the next codon (n+2) at the "A" site.

"P" site.

Fig.2.
This figure shows the steps of formation of a polypeptide
chain. The "P" and "A" binding sites are shown within a schematic
diagram of a ribosome.

(Figures 1 and 2 taken from Molecular

Biology of The Gene, 3d ed.

by J.D.

Watson.)
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m-RNA to a ribosome which splits into two subunits.

A

complex is formed with the smaller subunit (30S), the t-RNA
carrying the first amino acid, which is always formylated
methionine, and the m-RNA molecule. This complex is joined by

t;tJS~

the larger ribosomal subunit (70S) which completes the full
ribosome along which protein synthesis can occur.
proteins assist in all of these attachments.

Specific

Each ribosome

has two places for the t-RNA to a·ttach to m-RNA.
called the P (peptidyl) and A (amino acyl) sites.

These are
Each

attachment locus on m-RNA is made up of three nucleotides
called the codon which codes for one of twentv amino acids.
The anticodon, three complementary nucleotides on a loop of
the t-RNA, binds to the m-RNA codon.
acid is coded for.

Thus the proper amino

When both the P and A binding sites are

filled, peptidyl transferase, an enzyme, joins the amino
acids together, and the first t-RNA moves out of the P
binding site, leaving the two amino acids, formylated
methionine and the second amino acid, attached to the t-RNA
occupying the A site.

Now the m-RNA and the ribosome move rela-

tive to each other, and the t-RNA carrying the two unit peptide
chain is positioned in the P site.

The now vacant A site accepts

another t-RNA with its associated amino acid, which attaches to
the growing peptide chain by a repetition of the above process.
Thus, a protein is synthesized from the information coded originally on DNA.

The time required to complete this process for a

protein containing 300 to.400 amino acids is about 10 to 20 seconds.

11

Termination is accomplished by specific codons on the m-RNA
that are not complementary to a t-RNA anticodon, but are read
by specific protein release factors that stop elongation of
the chain and release the t-RNA at the terminal end.

Note that

many ribosomes can attach to an m-RNA at once, thus several
.
.
h es1ze
.
d s+mu
.
1 taneous 1 y. 14
po 1ypept1. d e c h a1ns
can b e synt

The last area of relevant background is natural recombination.

Recombinants have been observed even as early as

Mendel's garden pea experiments.

The recombinant part of

his experiments dealt with the breedinq of oea olants differinq
in more than one character, in this case, round versus wrinkled
and yellow versus green.

Mendel showed that round and yellow

are dominant over wrinkled and green, that is if round and
yellow peas which over successive generations bred true were
crossed with wrinkled and green peas which also have bred true,
the resulting peas would have a phenotype (physical structure)
of round and yellow, but a genotype (genetic structure) of
RrYy.

(R is round, r is wrinkled, Y is yellow, andy is green.)

The peas produced were called the F
cross~d

the F

resultinq

F~
~

1

1

generation. He then

generation within itself and found that the

qeneration had the followinq phenotypes:

the two

oriqinal phenotypes (round, yellow; wrinkled, qreen) plus two
new tvpes, the recombinants, wrinkled yellow and round oreen.
The interpretation is that any one qamete from the F1 qeneration
contains all the possible combinations of traits from each qene
pair.

Therefore, RrYv would vield four possibie qametes:

RY,

12

rv, rY, Rv, but never Rr, Yv, YY, or RR.

All four of these

qamet.e s are produced in virtuallv eoual numbers, and there is
i.ndepe.ndent assortment of all the aenes.

The result is obtained

bv takina all possible combinations of RY, Rv, rY, rv, to
produce the followinq ratio:

9 RY (round, vellow) , 3Rv (round,

green), 3rY (wrinkled, vellow), lrv (wrinkled qreen).

The

middle two ohenotvoes would be recombinantst that is, thev have
expressed both a dominant and a recessive trait as a result of
a new recombining of gametes.
This above phenomenon was explained using chromosomal
theory in 1903 by Sutton, in his paper, The Chromosomes in Heredity.
He said that the chromosomes are diploid and exist in identical
pairs and during meiosis each gamete receives only one chromosome
of each homologous pair.

Thus, one pair could carry the gene

for shape and another pair carry the

g ~ ne

for color.

Thus a

gamete from the F 2 generation could easily have any one of four
possible color/shape combinations.
If, however, two qenes for distinctly different traits are
located on the same qene, they will not underqo independent
assortment.

Thus, the number of qroups of linked qenes should

equal the number of chromosomal pairs.

However, this is never

100% true. The Belgian cvtologist, Janssens, first described
the mechanism of crossing over.

When meiosis begins, homologous

chromosomes pair at a synapse, parallel to each other.

Then

the chromosomes of each duplicate, thus giving four parallel

···__:__-_--:_·l.:___:_ · -
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strands, or a tetrad of chromatids.

The chromatids coil,

causing tension which breaks two chromatids at corresponding
places and they cross over and recombine with the other chromatid.
The closer genes are on a chromosome, the less likely a break
will occur between-them, thus by studying recombinants of
crossing over, an effective method of mapping the genes was
15
d,iscovered.
Random transfer of genetic material has also been observed.
In the process called transformation, fragments of DNA are
replicated and pass into the environment by excretion, or alternatively, a dying cell releases DNA fragments as its cell membrane
rupture_s.

Another cell, which is in a state of competence, will

allow these fragments to enter through the cell membrane.

The

recipient cell is termed to be in a state of competence when it is
not producing DNA-ase, an-enzyme which would break up the DNA
chain when it reaches the cytoplasm, and when the cell membrane
lacks its normal thick capsule which would not allow passage of
macro-molecules such as DNA.

Once the DNA fragments are within

the recipient cell, there is only a five percent chance that the
fragments will be similar enough to a segment of the host DNA that
recombination will occur.

If recombination does occur, the DNA

fragment will become incorporated into the cellular DNA, with
production of proteins coded for by the new DNA segment.

If the

newly produced proteins are toxic, a relatively harmless bacteria
could become a source of toxic materials·.

14

Another method of DNA exchange can come in the form of
·conjugation, where cells of the same species exchange genetic
material.

Conjugation is well documented in the bacteria

Escherichia coli, which is a normal inhabitant of the lower
intestinal tract of most primates, and has a circular DNA strand.
The cell which initiates conjugation has a plasmid, in addition
to its circular DNA.

The plasmid is a piece of independent DNA

that carries anywhere from 1 to 250 genes, and there can be as
many as thirty plasmids per cell.

The plasmid may replicate at

any time, independent of the replication of the cell's ''main"
genetic material.
A plasmid is responsible for forming the sex pilus, a cellular
extension which links two cells and enables the cell with the
plasmid, called an F factor, to physically transport a copy of
its circular DNA into the recipient cell.

This is accomplished by

the replication of the donor's DNA, and then a restriction
endonuclease, an enzyme coded for by the F factor, cleaves the
copy at a specific point.

Now the DNA can pass through the sex

pilus linearly, with the F factor attached to the end of the DNA
that will enter the recipient cell last.

Very seldom will the

entire DNA copy and F factor pass through because the DNA is
extremely fragile and usually breaks before the entire conjugation
process is complete.

Partial conjugation is sometimes referred

to as sexduction.
One danger of recombination can be seen in the activity of

15

plasmids.

It has been found that many plasmids carry genes

which code for proteins which resist the actions of many antibiotics, such as penicillin or streptomyocin.
to these drugs is passed on by conjugation.

The resistance
Staphlococcus

bacteria are especially noted for this phenomenon.

There are

certain plasmids in E. coli which produce antibiotics known as
colicins which kill off E. coli's competition in the primate
intestine, and let E. coli proliferate, causing serious intestinal
disorders.
A cell may obtain extracellular DNA via bacteriophages and
viruses.

A bacteriophage contains only DNA surrounded by a protein

coat.

It has a tail of protein fibers used for cellular attach-

ment.

A virus contains either DNA or RNA, but never both.

It,

too, has a protein coat, but usually does not contain the elaborate
attachment fibers of the bacteriophage.

In action, the bacteria-

phages are restricted to bacteria; viruses are found in cells
making up larger organisms.
In the process known as transduction, a bacteriophage inserts
its DNA into the host cell, leaving the protein coat outside the
cell.

Proteins coded for by the phage DNA rapidly break down host

DNA and use cellular ribosomes for new protein coat production.
New phages are produced that carry fragments of the host's DNA
along with their own DNA.

At this point, the cell lyses (splits

open) and releases the phages into the environment.

The phages

find new hosts, and the DNA of the phage, still containing frag-

16

ments of the former host's DNA, may recombine with the new
host's DNA.

Thus, phages serve as a vector for the transfer of

DNA from one cell to another.

It is also possible, using the

proper bacteriophage, that such transfer can occur between
bacteria of different species.
In some cases, the viral DNA will be inserted into the
cellular DNA and remain dormant through several cell divisions.
Thus, many copies of the viral DNA are made when the host DNA
replicates just before cell division and the cells produced have
a differing genetic makeup because of the viral DNA insertion.
Proteins from this insertion may or may not be expressed, depending
on the environment and state that the cell is in. 16
Recombinant DNA technology has its origin in the principles
expressed above.

Basically, this type of experiment involves

chemical synthesis or isolation of one or more genes from an
organism followed by an insertion of this DNA into the DNA of a
host organism.

This insertion is done in such a way that the

host will replicate the inserted gene along with the host's original
DNA.

The replication of the gene insertion by the host cell is

referred to as cloning.

The word cloning as used here refers to

the replication of foreign DNA inside a host cell, and not the
complete copying of a higher organism.
The most widely used organism for recombinant DNA experiments
is Escherichia coli, because its genetic structure and biochemistry
have been the most extensively studied of any organism.
easy to obtain and grow in extremely pure cultures.

It is

The most widely

17

used strain is the K-12 strain of E. coli which exists naturally
in the environment, but does not colonize the human intestinal
tract.
Restriction endonucleases, previously mentioned in conjunction with the F factor and conjugation, have been found in many
other forms and there exists specific endonucleases that cleave
at specific sites on DNA.

The most useful of these used in re-

combination experiments are those which produce DNA fragments with
"sticky" ends.

"Sticky" ends result from the cleavage of DNA at

recognition sites known as palindromes.

In the English language,

a palindrome can be read as the same phrase both left to right and
right to left, for example, "MADAM I'M ADAM." In DNA, such a sequence would be:

C

T
II
A

Ill

G

'r

A

II

II

A

T

A

G

II

Ill

T

c

which, if in a plasmid, could be cleaved by the proper restriction
endonucleas e ,

A.

--c
Ill

T

,--...__ G -----

T

II

A

/- G - -

1/1

II

.----A A T T C ,..____..

Now, if another DNA sea uence were cleaved b v the same endonuclease,
with the exception that it has a series o f other nucleotides
f o r mi ng a g e n e b etwe e n t h e G and A , we would s ee :

B.

~ --- G\

IlL

----- A A T T C

t

lC
T
Ill

(n e w g e n e)

T A A ,....._....

G ~---
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ancl

C.

B.

ilT'c

-----c

joi.nnd

T T

!Jy a

A A

~t

lie<~: ; t·

(! llzyrne

r

T T

l.o

yield:

A A G r-'

~~/ ~ ~ ~ ~ 1~(new gene)~1 ~ ~ ~ ~ ~ ,___
1 1

The restriction ligase catalyses the formation of the
phosphodiester bonds to yield an intact strand.

Once the amino

acid product of the recombinant is known, it can be sequenced,
and the DNA sequence of the gene it came from can be preclicted.
Thus, certain genes can be synthesized in the laboratory, rather
than isolated from a cell.
Once the plasmid has been recombined with the desired DNA
segment, it can be inserted into a host cell, usually the bacteria
Escherichia coli, and the cloning will. occur.

Normally, the

host cell is not harmed by having as many as 100 plasmid copies
inside it.

To tell exactly which cells have the plasmid and which

do not, the plasmid used contains a gene for antibiotic resistance.
After the recombinant plasmids have been mixed with the desired
host cells, an antibiotic is administered.

Those cells that

survive are the ones which have incorporated the plasmid.
In order to insure that the newly incorporated gene will

19

synthesize a desired protein, the gene must be recognized by
the host system as being part of its DNA.

This is done by

splicing the gene into a section of the plasmid that is next to
a DNA sequence that controls whether or not the gene will be
17
transcribed.
An excellent example of the utility of the recombina·nt DNA
technique is in the production of the mammalian peptide hormone
somatostatin.

Somatostatin inhibits the secretion of a number of

hormones including growth hormone, insulin, and glucagon.

It has

value in the treatment of pancreatitis and insulin dependent
diabetes.

Conventionally, it has been isolated in milligram

quantities by extraction of the ground-up brain tissue of a half
million sheep.
'

The DNA responsible for the production of somatostatin using
recombinant DNA techniques was chemically synthesized and not
isolated from mammalian DNA.
ligase enzymes.

The DNA fragments were linked using

The gene was then inserted in a bacterial plasmid

between a gene control sequence and a naturally occurring gene for
a bacterial protein.

Thus, the somatostatin was produced as

an addition to the normally produced bacterial protein, and was
not destroyed by the cell's natural defense systems.

However,

in this form, the somatostatin was not useable, so it was cleaved
from the bacterial protein using
cyanogen bromide.

chemi~al

methods involving

One hundred grams of bacteria grown in approxi-

mately sixteen liters of culture resulted in milligram quantities
18
of active somatostatin being produced.

20

Another development showing the utility of recombinant
DNA techniques involves the manufacture of insulin by Genetech
Laboratories in California.

The gene coding for the protein

insulin has been isolated from pancreatic cells and

in~erted

into the DNA of E. coli by a method similar to the one used to
.
19
insert the somatostatin gene into a bacterial plasm1d.
In agriculture, recombinant DNA techniques are being used
to enhance the efficiency of nitrogen fixation.

All plants,

including crop plants, need nitrogen in a useable form, such as
ammonia, in order to sustain life.

By recombination, the gene

for nitrogen fixation may be isolated from bacteria which
naturally exhibit this activity (which converts N2 in the atmos+
phere to NH 4 , ammonia). The isolated gene could be placed in
the DNA of a crop plant, making the crop plant fix nitrogen for
itself.

Another possibility is that the qene could be placed

in a bacteria or alqae known tO be part of the natural flora
of the soil in which the crop grows.

Then the source of ammonia

for the plant would be the bacteria in the soil.

Fertilization,

which requires the makinq of fertilizer from petroleum products,
could be vastly reduced. 20
Other potential benefits, which will only be briefly mentioned here, include the discovery of the mechanism of gene regulation in mammalian systems, nucleotide sequencinq in the complex
DNA of higher animals and methods of differentiation of cells
within the human embryo.

Not only could inherited disorders be

21

pinpointed as to cause, but there is the possibility of gene
repair to correct such defects by recombinant techniques. The
manufacturing of pharmaceutical products could be Inade more
efficient by reducing the use of animal tissue extracts.

Proteins,

such as the human clotting factor for hemophilacs, could be
isolated in highly pure form.

In cancer research, the protein

interferon has been found to be a possible therapeutic substance
with low toxicity.
that

However, it is found in such low quantities

research concerning it has been slow at best.

The cloning

of interferon in bacteria is a possible means of obtaining
workable quantities of the protein.

Vaccines could be prepared

in bacteria, using bacterial plasmids as the attachment point
for viral genes.

This would eliminate contamination by unidenti-

fiable viruses in the vaccine culture, a phenomenon which plagues
chicken embryo vaccine cultures that are presently used. 21
The orosoects and Possibilities seem endless.

Recombinant

DNA techniques seem to be almost a oanacea for even the qreatest
~uman

scourqes.

But from the outset of this tvoe of work, there

were many scientists who warned against the misuse of gene control
and manipulation.

In the May, 1974, Proceedinqs of the National

Academv of Sciences, Cohen and Chanq from Stanford, Baver,
Hillinq, and Goodman from the University of California at San
Francisco, and Murrow of Johns Hopkins. reported the successful
combininq of animal qenes with a bacterial DNA strand.

The re-

combinant DNA formed was called a "chimera," from the hideous
monster of incongruous parts in Greek mythology.

22
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Shortly after this announcement, eleven scientists, making
up the Committee on Recombinant DNA Molecules under the National
Academy of Sciences, wrote a letter* requesting a ban on three
types of recombinant DNA experiments.

Type I is the addition of

genes to bacteria that would confer antibiotic resistance or
cause the production of a toxin not normal to that bacteria.
Type II is linking DNA from tumor causing viruses to bacterial
plasmids.

Type III is the combining of animal cell DNA with

bacterial DNA.
The letter stemmed from a meeting of the Gordon Research
Conference on Nucleic Acids in 1973, in which Paul Berg of Stanford University formed a committee which began the investigation
of the problem under the auspices of the National Academy of
.
23
Sc1ences.
Some members of the committee were actively involved
in recombinant DNA experiments, including Cohen and Boyer from
Stanford, and Daniel Nathans, whose work on restriction enzymes
in 1969 started the field of recombinant DNA research and won for
him a share of the 1978 Nobel Prize in Medicine. 24
Immediately, there was a furor in the scientific community.
A new precedent had been set, that is, scientists asking other
scientists to curtail research, and to decide among themselves,
25
. pu bl'1c, h ow an d/ or 1' f recomb'1nant DNA researc h was t o cont1nue.
.
1n
To compound problems, the ·potential benefits and risks were purely
speculative, as no previous work had been done on genetic material
crossing the species barrier.

* APPENDIX

I
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Speculative risks incl de animal tumor viruses which might
contaminate community air a d water supplies or the escape into
rml~ss

air and water of normally h
additions coding for toxic

bacteria containing gene

~roteins. 26

Since E. coli is a natural

inhabitant of the human intf stinal tract, fears exist that recombinant E. coli could

esc~pe

vectors, and cause massive

a research laboratory via human

pidemics of intestinal disorders, or

infections of the blood str.am.

It has also been found that one

segment df DNA may encode f r several different proteins, depending
on the location of the segm$nt in question in relation to the segment being transcribed.

Inlother words, an inserted segment

might code for one protein

~Y

itself, plus be at the beginning of

the code for another protei , and at the end of the code for yet
another.

This overlapping

always be predicted, and thus the

proteins from a single reco
and unpredictable.

inant insertion may be quite varied
I
I

The above stated negat t ve aspects of the research, spurred on
by the self-imposed morator urn, caused a tempest of press interest.
Scientists who were used to a secluded atmosphere of research and
decision making were sudden y thrust in front of the camera artd:
microphone.

The main issue to the public was safety and head-

lines like "Bid to Ban Test Tube Super Germ" left the public with
an impression of a f ew mad- · ap, eccentric scientists fooling
around with dangerous subst nces for lack of anything better to
work on.
The f i rst attempt a t s If- regulation took p l ace in an a tmos-

24

phere of eagerness to clear up the safety issue and put the facts
before the public.

One hundred forty scientists from seventeen

countries gathered at Asilomar, California, in February of 1975,
to discuss effects of the now eight-month old moratorium on research with recombinant DNA and to come up with recommendations
that might permit the research to continue.
The first three days of the conference were mostly condolence
sessions.

Scientists were telling each other that their research

was too good and important for safety regulations to intrude.
It was observed by one person as like

having the chairman of

General Motors write the specification for safety belts."

28

However, the evening before the final session, three lawyers gave
presentations on the legal aspects of the research and the legal
responsibilities of the researchers.

The final speaker of the

three, Professor Harold Green of the George Washington University
Law School, hit home with his topic, "Conventional aspects of
the law and how they may sneak up on you--in the form, say, of a
29
multi-million dollar lawsuit."
The results of the final session showed the impact of the
previous evening's speakers.

A two-point safety program was

outlined, one part dealing with physical laboratory containment
of recombinant molecules and organisms, based on risk.

The

second point was a novel concept of biological containment, where
a strain of E. coli was to be developed that would not colonize
30
in the natural environment.
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The next major step in regulation was taken by the National
Institutes of Health.

Basically, the NIH detailed the physical

and biological containment recommendations of the
Conference.

As~lomar

These guidelines, explained briefly below, were

published in June of 1976. 31
Physical containment will be discussed first, followed by
biological containment.

The lowest level of physical containment,

Pl, involves the standard microbiological procedures of sterile
technique and autoclaving.

Open bench tops may be used, but all

wastes must be stored and decontaminated daily before release into
the environment.

Experiments using Pl can at most involve·

transfer of genetic material resulting from biological gene exchanges that can occur in nature.

The P2 level involves experi-

ments that use bacteria that do not naturally exchange

g~nes.

It uses the same procedures as Pl, plus restricted entrance to
the laboratory,

32

and an open front cabinet with inward air flow

over the work surface, so that bacteria laden aerosols do not
contaminate the worker.

The air exhausted to the environment by

these cabinets is first filtered to remove 99.997 percent of the
organisms present in the air.

At the P3 level, all of the above

would be used, plus protective gloves, wrap around disposable gowns,
and vacuum systems protected by filters and disinfectant traps.
The P3 room itself is isolated from all other laboratories; air
pressure is slightly below outside pressure so that organisms can
pass in but not out when the doors are opened, and double door

26

systems are used.

Ultraviolet light shields are used in all

hoods in the laboratory.

Experiments done under these conditions

include use of embryonic, vertebrate and primate tissue, and DNA
transfer from these tissues and their tumors to "crippled" host
systems.

"Crippled" hosts will be discussed under biological

containment.

P4 procedures are maximum containment, using

class III cabinets used within the laboratory of all conduits.
The class III cabinets used within the laboratory are gas tight
and all materials passing in or out of them must be autoclaved.
This requires attaching an autoclave to the cabinet.

A second

sterilization must be done before any materials leave the laboratory proper.

Personnel entering and leaving the laboratory

must shower and wear completely separate clothing when in the
laboratory.

Under the original regulations, P4 facilities would

accommodate any recombinant DNA research, except DNA from cancer
causing viruses, pathogens, drug resistant organisms, or genes for
toxins.

These experiments would be completely banned.

Experience with these procedures of containment has been
gained in the biological warfare laboratories of Fort Detrick,
Maryland.

The infection rates for workers in similarly equipped

laboratories ranged from 7 infections per 100 person-years worked
for Pl to 0.4 infections per 100 person-years worked for P3.
P4 data is not available as no lab meeting such stringent requirements has even been built.
progress at Fort Detrick. 33

Construction of a P4 facility is in
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Biological containment, using so called "crippled" hosts
contains recombinant DNA molecules in vectors that will not
endanger the environment.

Usually, these "crippled" hosts are ones

that will only survive in the laboratory, or will self destruct
by not possessing the genes to synthesize their own cell wall or
replicate DNA outside of a narrow environment.
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E. coli K-12 was the first strain used in biological containment because of its inability to survive more than 48 hours
within the human intestinal tract.

It was originally isolated

from a human patient 50 years ago and since then has been cultured
under laboratory conditions with regularity.

However, approximately

1 in every one hundred million cells will pass through the intestinal tract unharmed.

In March, 1976, the NIH approved a safer

host strain of E. coli K-12 developed by Roy Curtiss of the University of Alabama, and dubbed it E. coli K-12 Chi 1776.

Chi 1776

requires certain laboratory nutrients, is sensitive to bile salts,
and is destroyed by sunlight. 35
Another method of biological containment includes the use of
the Charon Lambda bacteriophage, where the recombinant molecule
is not

in a bacteria, but is present in a type of virus that only

attacks bacteria.

The bacteriophage only stays in the bacteria

long enough to replicate, then lyses the cell.

Propagation by

these means outside the laboratory is extremely difficult. It has
10
.
been found that fewer than 1 in 10
phages survive stomach conditions

(pH 3 for 2.75 hours), fewer than 2 in 10 7 survive 30 minutes

in detergent conditions (1 percent sodium dodecyl sulfate) and

28

fewer than 3 in 10 6 survive in raw sewage.

Those that do survive

however, do not encounter bacteria in natural surroundings that
will support their growth.

There are two strains of. bacteria

used for their growth in the laboratory, E. coli Chi 1953 and
Chi 2098.
K-12.

Each has a survival rate 1000 times less than E. coli

Neither colonizes the human or rat intestinal tract.
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The year after the publication of the NIH guidelines, there
were two important sets of hearings on the recombinant DNA research issue.

The National Academy of Sciences Forum reviewed

the advances in developing safe strains of E. coli and heard
scientists who presented their cases concerning pharmaceutical
and industrial applications, food production, genetic engineering,
and problems of regulation and control.

This forum differed

from the Asilomar Conference in that the atmosphere was both
philosophical and safety oriented indicating that more scientists
were willing to take a long, hard look at recombinant DNA research
before going into it headlong.

Excerpts of this forum have been

previously cited.
The other siqnificant hearings were held before the SubA
~ ~

committee on Science, Research and Technology of the Committee on
science and Technology, United States House of Representatives.
These hearings were similar in content to the NAS Forum and were
also characterized by a philosophical slant on the future uses of
the technique and public involvement in decisions concerning
recombinant DNA research.
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Philosophically,-

a major question has been how far should

we go with the recombinant DNA techniques.

Critics contend

that the possibilities of bio-hazards have not been resolved,
but merely covered up.

They claim that even one case

of

bacterial escape from a containment facility will prevent a recontainment of it or its prodigy.

Dr. Ruth Hubbard of Harvard

asks how safety guidelines can be established when the risks are
unpredictable and unquantifiable.

Dr. Willard Gaylin warns that

by nature, disasters are not anticipated, otherwise, they are
prevented.
Inherent to the technique is the potentially dangerous
violation of three billion years of evolution.

According to

Dr. Robert Sinsheimer, we cannot prove that such "quantum jumps"
in genetics occur naturally in the evolutionary process.

Some

feel that this technique will take the path of nuclear technology,
demonstrating itself in a "Hiroshima style" with a disaster caused
by an escape of a lethal recombinant DNA chimera, followed by
more peaceful, but nonetheless controversial uses such as genetic
engineering on human cloning.

According to those who oppose genetic

engineering, the proliferation of

recQ~binant

DNA techniques would

encourage a symbiotic relationship between geneticists and social
visionaries who envision a "super race" much as was done during
Hitler's Third Reich.37
Those who favor recombinant DNA research usually have accepted
the NIH guidelines and believe that genetic engineering in humans
is f ar fe tched and not applicable to the direction of the research
at the present time.

It is the safety factor rather than the
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philosophical factor which concerns citizens.
Dr~

Sheldon Krimsky served on the Cambridqe (Massachusetts)

Experimentation Review Board, which advised local officials
whether recombinant DNA procedures should be allowed in the city.
The citizen review board unanimously voted to allow the research
up to the P3 level.

However, the committee also required research

to have separate requlators and promoters, additional review and
monitorinq of the facilities, done by a qroup independent of the
.

.

.

.

sponsor1nq 1nst1tut1on.
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In other cities, the same concern was arising, especially in
those towns with large universities or pharmaceutical firms.
Ann Arbor, Michigan, has both.

Albert Wheeler, the mayor in 1977,

stated that he is concerned that the NIH guidelines have not
been enforced in industry.

In testimony before the House Sub-

committee on Science Research and Technology, Mr. Wheeler said
that he would allow research up to but not including the P4 level,
and city officials would have to be notified when recombinant DNA
experiments were being done at any level.

He also proposed the

formation of a citizens review board on the subject.
The apparent lack of acceptance of NIH guidelines in industry
is unfortunate, but the increasing influence of citizen review
boards may force compliance. 39 Groups such as Genetics Group of
Science for the People have pressured industry to comply with
NIH guidelines and have included the general public in the decisionmaking process on allowing recombinant DNA experiments to be done
40
in their communities.

31

In a statement by the Pharmaceutical Manufacturers Associa- ···
tion, acceptance of NIH guidelines by that group and most pharmaceutical manufacturers seemed widespread.

In early_ 1977, NIH

proposed a national registry for all recombinant DNA work, and
the PMA seemed likely to accept this measure also.
Most environmentalists ask for strict controls and along
with them, prominent anti-DNA research scientists have asked
that all recombinant DNA work be carried out in P4 facilities.
This, in 1977, would have amounted to a complete ban on recombinant DNA work, as no P4 laboratories were in existence.
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Presently, only the NIH and Fort Detrick, Maryland, have the
proper P4 facilities.
Actual DNA legislation was proposed in early 1977 and for
the most part, placed tremendous restrictions on recombinant
DNA research.

However, in late summer of 1977, many Congressmen

backed away from their "worst case scenario" philosophy, at the
urging of scientists and industry alike.

One of the most

tenable sets of principales was proposed by the American Society
for Microbiology which basically asked for a national regulatory
commission, preemption of local or state laws by federal regulations,
and fines for failure to comply with federal legislation.
The A.S.H. principles caused Senator Edward Kennedy to withdraw his bill that would virtually halt recombinant DNA work and
caused relaxed revisions in both House and Senate bills dealing
42
'th recomb'~nant DNA researc h regu 1 at~on.
.
w~
A major question

still stands unresolved and that is of
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enforcement.

In the research done on the insulin gene and its

transfer to bacteria, a vector was used that was not NIH approved
as a biological containment vector.

This prompted the statement

that among those in graduate research, some follow the guidelines
to a degree, others not at all, and it seems ''almost chic not to
know the NIH rules."

Even if the vector were safe, the.question of

unfair advantage arises.

Are those who abide by the rules being

taken advantage of by those who do not?

The short time it took to

produce a successful insulin producing bacteria indicates that an
. a d vantage may b e poss1'bl e. 43
un f a1r
The last section will describe events in recombinant regulation durinq 1978.

In the July 28, 1978, Federal Register, the

NIH published revisions of the original NIH guidelines for work on
recombinant DNA.

The major revisions include:

1.

Exemption from the restrictions of the guidelines
certain experiments which are now considered to be
safe.
(Most of these experiments fell under the
old Pl containment requirements.)

2.

Placing primary responsibility for assuring guideline
compliance on the institution where research is done.

3.

Dropping the requirement for NIH notification when a
Pl experiment was changed to a P3 experiment.

4.

Providing voluntary registrc:'ion of recombinant DNA
experiments.44

During hearings before the Senate Subcommittee on Science
Technology and Space, a recommendation was made that the current
NIH guidelines should not be enforced by the NIH but by another
unnamed agency.

They also suggested that all laws regulating the
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research be national laws with a deemphasis on local and state
regulations, except in special cases.

In a minority report

Senator Harrison Schmitt said the recommendations would result

45
in "umvarranted and excessive regulations."
As an additional signal that regulations and bans were relaxing within the scientific community, Genetech, Inc. agreed
to work with Eli Lily and Company to manufacture insulin by
insertion of artificial insulin genes into plasmids of E. coli.
46
Large scale production is predicted in 2 to 5 years.
However,
bans and restrictions have not been so much the issue this year
as has the role of the NIH.

Prompted by the Senate Hearings

during the late summer, a public hearing was held in Washington to
discuss the proposed revisions in NIH guidelines.

Very little

medium ground was covered; the guidelines were either too stringent
or too relaxed.

Ambiguities were pointed out often.

The NIH

planned to publish final revisions, based on the hearings in

47
November, 1978.
Finally, Joseph Califano announced the revisions in the NIH
guidelines.

Basically, they were unchanged from the guideline

changes mentioned previously, but the reporting procedures for
violations, illness, and accidents were clarified .

The NIH re-

tained control over recombinant DNA guidelines, but greater public
representation in hearings and decision on policy was required.
Therefore, the recombinant DNA question has not been completely
resolved, but an interim set of guidelines that have shown themselves
adaptable to new facts and findings may help us to control a new
and powerful research tool.

48
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In writing this paper, the author was amazed at the number
of plausible arguments both for and against continued use of
recombinant DNA techniques.

It seems that each potential risk

is counterbalanced by an equally convincing benefit.

It would

be ridiculous to assign numerical values to each risk and benefit and settle the question forevermore by a mere bookkeeping
system.

Each

individua~

experiment must be judged primarily on

its specific risks and specific benefits, and secondarily, on its
relationship to other recombinant DNA experiments and vice-versa.
However, we must have broad guidelines to assist not only
our cost-benefit analysis of individual experiments, but also to
insure that once an experiment is approved for use, the experiment
will be done safely.

A safe experiment is one that combines bio-

logical and physical containment procedures such that organisms
containing artificially recombined DNA will not be able to reproduce
in the environment.

In this writer's opinion, the current NIH

guidelines, if enforced, would accomplish this goal.

It must be

noted that these guidelines must be open to change, as basic research reveals more about the nature of recombinant DNA techniques.
The purpose of the NIH guidelines should not be to dictate a set
of one time rules, but to be flexible guidelines with respect to
the current findings of basic research in the area of recombinant
DNA.
Another major factor to consider is enforcement of the guidelines.

A workable set of guidelines without enforcement are of

little value.

Enforcement must come from the national as well as
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local levels.

Communities must take more responsibility towards

deciding what types of experiments should be allowed to take
place in 'their institutions, both academic and industrial.

How-

ever, the communities must also have the assurance that a federal
agency will back them up in their decision.

Here again, we see

that the federal government must show flexibility 1n guidelines
and in recognizing the rights of communities to make intelligent
decisions of scientific importance.
This writer certainly does not call for a ban on recombinant
DNA research.

Rather, there should be regulations, such as the

current NIH guidelines that can change as current knowledge dictates.

There should also be enforcement from both the community

and federal levels in order to assure compliance with research
guidelines.

The future of recombinant DNA research lies not in

doomsday scenarios of plague caused by recombinant bacteria.

Nor

does i t lie in surrealistic extrapolations of potential uses,
such as human cloning and super-races.

The future of recombinant

DNA research lies in the scientists' ability to conduct accurate
research within the bounds set mutually by science and society,
each being willing to change their position as the facts permit.

f.?'"'
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Sciences give consideration to these
mattl·rs. Thl· undersigned member~ of
Recombinant DNA Molecules
a committee. acting on behalf of ami
with the endorsement of the Assembly
Recent advances in techniques for
of
Life Sciences of the National Rethe isolation and rejoining of segments
search
Council on this matter. propose
of DNA now permit construction of
the following recommendations.
biologically active recombinant DNA
First. and most important, that until
molecules in vitro. For example. DNA
potential hazards of such recomthe
restriction endonucleascs, which genbinant
ON A molecules have been better
erate DNA fragments containing coevaluated or until adequate methods
hesive ends especially suitable for rearc developed for preventing their
joining. have been used to create new
spread, scientists throughout the world
types of biologically functional bacjoin
with the members of this comterial plasmids carrying antibiotic remittee in voluntarily deferring the folsistance markers (I) and to link
lowing types of experiments.
Xenopus lael'is ribosomal DNA to
.,.. Type I: Construction of new,
DNA from a bacterial plasmid. This
autonomously replicating bacterial plaslatter recombinant plasmid has been
mids that might result in the introducshown to replicate stably in Escherichia
tion of genetic determinants for anticoli where it synthesizes RNA that is
biotic
resistance or bacterial toxin
complementary to X. lat'l'is ribsomal
formation into bacterial strains that dn
DNA (2). Similarly. segments of
not at present carry such determinants;
Drosvphila chromosomal ON A have
or
construction of new bacterial plasbeen incorporated into both plasmid
containing combinations of remids
and bacterillphagc ON A's to yield hysistance In clinically useful antibiotics
brid mokcules that can infect and
unless plasmids containing such comreplicate in C. coli Ln.
binatillllS of antibiotic resistance deSevcr~tl groups of scientists arc now
terminants alrc<tdy exist in nature.
planning to usc this technology to
...,. Type 2; Linkage llf all or segcreate recombinant DNA's from a
ments of the ON A's from oncogenic or
variety of other viral, animal, and
other animal viruses to autonomously
hach:rial ~lllirccs. Althnugh such experireplicating DNA clements such as ba~
ments arc likely to facilitutc the solutcrial plasm ids or other viral DNA's.
tion of important theoretical and pracSuch recombinant DNA molecules
tical biologica I problems, they would
might be more easily disscminatcJ to
also result in the creation of novel
bacterial
populations in humans and
types of infectious ON A clements
other species, nnd thus possibly inwhose biological properties cannot be
crease the incidence of cancer or other
completely predicted in advance.
diseases.
There is scriO!JS concern that some of
Second, ph111s to link fragments of
these artificial recombinant DNA moleanimal DNA's to bacterial plasmid
cules could prove biologically hazardDNA or bacteriophage DNA should he
ous. One potential hazard in current
carefully weighed in light of the fact
experiments derives from the need to
that many types of animal cell DNA's
usc a hacteriun) like t:. coli to clone
cnntain SCI.JUCnccs common to RNA
the recombinant ON A molecules and
tumor viruses. Since jllining of any
10 amplify their numb~.:r. Strains of
foreign DNA to a DNA replication
£. coli commonly reside in the human
system creates new recombinant ON A
intestinal tract, and they arc capable
molecules whose biological prope rtics
of exchanging genetic information with
cannot be predicted with ccrt~Iinly,
,,ther types l'f bacteria. some of which
such experiments should not be underare pathl'gcnic to man. Thus, new
taken lightly.
DNA ekmcnts introduced into £. coli
Third, the director of the National
might possibly become widely disInstitutes of Health is requested to give
.,eminatcd among human, bacterial,
plant, or animal populations with unimmediate consideration to establishing
predictable elf ccts.
an advisory commiltce charged with
( i) overseeing an experimental proConcern for these emerging capabiligram to evaluate the potential biologities was raised hy scientists attending
cal and ecological hazards of the above
the 197 3 Gordon Research Confertypes of recombinant ON A molecules;
ence on Nucleic Acids (4), who re( ii) developing procedures which will
quested that the National Academy of

Potential Biohazards of

minimize the spread of such molecules
within human and other populations;
an•l (iii) devising guidelines to be
followed by investigators working with
potentially
hazardous
recombinant
ON A molecules.
Fourth, an international meeting of
involved scientists from all over the
world should he convened early in the
coming year to review scientific progress in this area and to furl her discuss
appropriate ways to deal with the
potential biohazards of recombinant
DNA molecules.
The above· recommendations are
made with the realization (i) that
our concern is based on judgments of
potential rather than demonstrated risk
since there arc few available experimental data on the hazards of such
DNA molecules and (ii) that adherence
to our major recommendations will
entail postponement or possibly abandonment of certain types of scientifically worthwhile experiments. Moreover,
we arc aware of many theoretical and
practical difficulties involved in evaluating the human hazards ofi such recombinant DNA molecules. Nonetheless. our concern for the possible unfortunate consequences of indiscriminate application of these techniques
motivates us to urge all scientists working in this area to join us in agreeing
not to initiate experiments of types
I and 2 above until attempts have been
made to evaluate the hazards and some
resolution of the outstanding questions
has been achieved.
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